Inflammation

1.5 Credits / Immunology, Allergy

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology

1.5 Credits / Dermatology, Immunology

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.0 Credit / Immunology, Neurology

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Immunology, Pulmonology/Respiratory

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology

1.5 Credits / Allergy, Immunology

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

More News

March 19th 2022

Dupilumab Meaningfully Reduces Symptoms for Patients With EoE, Study Finds

Laura Joszt, MA

Compared with placebo, dupilumab treatment resulted in statistically significant and meaningful symptom improvements in adults and adolescents with eosinophilic esophagitis (EoE), according to abstracts presenting findings from the 3-part LIBERTY-EoE-TREET study.

March 16th 2022

AstraZeneca Receives CRL for Benralizumab in Chronic Rhinosinusitis With Nasal Polyps

FDA issued a complete response letter (CRL) to AstraZeneca seeking additional clinical data for benralizumab, sold as Fasenra, in the treatment of patients with inadequately controlled chronic rhinosinusitis with nasal polyps.

March 13th 2022

Incidence of Nasal Polyps Linked With Severe Radiographic Disease in CRS

Patients with chronic rhinosinusitis (CRS) with severe radiographic disease were more likely to report incidence of nasal polyps and be managed by endoscopic sinus surgery, but did not show greater health care utilization.

March 11th 2022

Study Examines Dupilumab's Effect on EoE When Given for AD, Other Conditions

Administering dupilumab for other atopic conditions, including atopic dermatitis (AD) and asthma, in patients who also have eosinophilic esophagitis (EoE), resulted in improved EoE symptoms.

March 8th 2022

Patients With CRSwNP, Comorbidities at Greater Risk for Revision Sinus Surgery

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who have comorbidities were more likely than those without co-occuring conditions to require revision endoscopic sinus surgery over a 10-year period.

March 5th 2022

Prevalence of Chronic Rhinosinusitis With Nasal Polyps Higher in Urban Residents, Seniors

In Poland, the prevalence of chronic rhinosinusitis with nasal polyps was shown to be greater in men, elderly individuals, and those living in urban areas.

March 2nd 2022

EoE Studies Examine Early Life Influences, Alignment of Parent-Child Reports

Abstracts presented at a recent meeting of allergists and immunologists explored early factors in disease development of eosinophilic esophagitis (EoE) as well as symptoms reported by parents and children.

March 2nd 2022

Novel Questionnaire Shows Promise in Determining HRQOL for CRS With Nasal Polyps

The nasal polyposis quality of life (NPQ) questionnaire was shown to be valid, reliable, and sensitive to individual changes in evaluating the health-related quality of life of patients with chronic rhinosinusitis with nasal polyps.

February 26th 2022

Second Phase 3 Trial Shows Dupilumab Improves EoE in Patients 12 and Older

During the annual meeting of the American Academy of Allergy, Asthma and Immunology, presenters said findings from a second phase 3 trial of dupilumab for eosinophilic esophagitis (EoE) continued to show the biologic improved symptoms in adults and adolescents.

February 26th 2022

Several Postsurgery Prognostic Factors Linked With Nasal Polyp Recurrence

Polyp recurrence occurred in more than 1 in 3 patients with chronic rhinosinusitis with nasal polyps who underwent endoscopic sinus surgery, with several prognostic factors linked with recurrence.

February 25th 2022

Dupilumab Found to Significantly Improve Sense of Smell in Patients With CRS With Nasal Polyps

Patients with chronic rhinosinusitis (CRS) with nasal polyps reported significantly reduced anosmia prevalence when given dupilumab vs placebo.

February 16th 2022

Asthma, Eosinophils Linked With Nasal Polyposis Recurrence

Asthma, aspirin-exacerbated respiratory disease, and nasal cytology were identified as predictors of chronic rhinosinusitis with nasal polyps recurrence.

February 12th 2022

Review Shows Evolution, Current Thinking on Managing Eosinophilic Esophagitis

Eosinophilic esophagitis is a complex disorder with significant health burdens and a recent review described how management strategies have changed over time.

February 10th 2022

An Overview of Recent Advances in Management of Chronic Rhinosinusitis With Nasal Polyps

Researchers reviewed advances in the management of chronic rhinosinusitis, with and without nasal polyps, from 2020 to 2021.

February 8th 2022

Postsurgery Factors Linked With Disease Control in Chronic Rhinosinusitis With Nasal Polyps

Patients with chronic rhinosinusitis with nasal polyps who had elevated serum amyloid A (SAA) levels were more likely to achieve disease-controlled status vs those with low SAA levels after endoscopic sinus surgery.

February 5th 2022

Patients With EoE Have High Level of HCRU, Analysis Finds

This retrospective study using administrative claims data examining health care resource utilization (HCRU) found that in the months before a diagnosis of eosinophilic esophagitis (EoE), other diseases were more commonly diagnosed.

February 4th 2022

Understanding Risk Factors, Treatment of Nasal Polyps in Children

Researchers discuss contributors to nasal polyp development in children, as well as the risk of co-occuring conditions and current methods of treatment.

February 2nd 2022

Sinonasal CT Scores May Predict Prognostic Features of Chronic Rhinosinusitis With Nasal Polyps

Sinonasal CT scores were associated with several prognostic features in the disease course of chronic rhinosinusitis with nasal polyps, including blood eosinophil counts and risk of relapse after endoscopic sinus surgery.

January 28th 2022

Researchers Try to Settle Question About Possible EoE, Celiac Link

A recent study examined a possible association in children diagnosed with celiac disease and eosinophilic gastrointestinal disorders.

January 28th 2022

Steroid-Eluting Implants May Reduce Health Care Utilization From Chronic Rhinosinusitis

Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following endoscopic sinus surgery.

January 26th 2022

Mepolizumab Associated With Significant Improvement of Chronic Rhinosinusitis With Nasal Polyps, Comorbidities

Mepolizumab was found to reduce nasal polyp size and nasal obstruction in patients with chronic rhinosinusitis with nasal polyps regardless of the presence of potentially exacerbating comorbidities.

January 22nd 2022

Endoscopic Sinus Surgery With Medical Therapy Effective for Chronic Rhinosinusitis With Nasal Polyps

Patients with chronic rhinosinusitis with nasal polyps were found to benefit more from the combination of endoscopic sinus surgery plus medical therapy vs medical therapy alone, although the minimal clinically important difference was not met.

January 20th 2022

For Some Toddlers, Oral Immunotherapy Led to Remission for Peanut Allergy

For the first time, a major study showed that remission for peanut allergy can be achieved even in very young children using oral immunotherapy.

January 19th 2022

Dupilumab Linked With Significantly Improved Patient Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps

Patients with severe chronic rhinosinusitis with nasal polyps achieved significant improvements in health-related quality of life (HRQOL) and general health status with dupilumab treatment after 52 weeks.

January 15th 2022

Analysis Shows Small Rate of Eosinophilic Esophagitis in Peanut Immunotherapy Trial

AJMC Staff

The eosinophilic esophagitis responded to treatment or resolved after the peanut oral immunotherapy stopped.

January 13th 2022

Air Pollution Exposure Found to Exacerbate Severity of Chronic Rhinosinusitis With Nasal Polyps

Short-term exposure to several different types of air pollution was found to significantly increase disease severity in patients with chronic rhinosinusitis with nasal polyps.

January 10th 2022

Immunoglobulin Levels Linked With Nasal Polyp Development

Local immunoglobulin levels were found to be significantly higher in polyp tissue specimens, but not in the blood, of patients with nasal polyps.

January 8th 2022

Risk of Chronic Rhinosinusitis With Nasal Polyps Greater in Patients With Diabetes

A significant link was found regarding incidence of diabetes and chronic rhinosinusitis (CRS) with nasal polyps, whereas CRS without nasal polyps was not associated with diabetes.

January 6th 2022

Dr David R. Stukus on the Increase in Eosinophilic Esophagitis

Maggie L. Shaw

David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, talks about the increase of eosinophilic esophagitis, or EoE, along with other allergic conditions.

December 27th 2021

Top 5 Most-Read Inflammation Articles in 2021